Metylenblått trihydrat CAS:7220-79-3

Methylene blue is an oxidation-reduction agent. The intravenous form of methylene blue is approved by the FDA for the treatment of pediatric and adult patients with acquired methemoglobinemia. Historically, it has been widely used in Africa to treat malaria, but now it disappeared when chloroquine (CQ) and other drugs entered the market. Its use as an urinary tract antiseptic has also been investigated.

Methylthioninium chloride (VERTSHUS, or methylene blue, proposed trade name Rember) is an investigational drug being developed by the University of Aberdeen and TauRx Therapeutics that has been shown in early clinical trials to be an inhibitor of Tau protein aggregation. The drug is of potential interest for the treatment of patients with Alzheimer's disease.

1. Mainly used for dyeing cotton, acrylic fiber, hemp, silk and paper, also used for coloring bamboo and making ink and color lake, and also used for dyeing biological bacteria

2. Used as REDOX indicator, adsorption indicator and biological stain

3. Bacterial stain.Mixed indicator for serum protein biochemical examination.Exfoliation staining solution was prepared.Prepare basic methylene blue stain.REDOX indicator.Determination of mercury and tin.Reducing titrant for precipitation of perchlorate and rhenate.Photometric determination of selenium and molybdenum with others.